<DOC>
	<DOCNO>NCT03029169</DOCNO>
	<brief_summary>Arrhythmias accompany septic shock increase rate ICU cohorts presence management related patientÂ´s prognosis . 1c class antiarrhythmic seldom administer intensive care due dose dependent toxicity publish case report unfavourable outcome report prospective trial do cardiology patient . The paper 1c class antiarrhythmic take consideration complex haemodynamic assessment use echocardiography . The author recently present retrospective study SV arrhythmias septic shock patient demonstrate favourable effect safety propafenone show high antiarrhythmic efficacy amiodarone .</brief_summary>
	<brief_title>Propafenone Versus Amiodarone Septic Shock</brief_title>
	<detailed_description>Primary aim verify conclusion retrospective study , i.e . efficacy safety propafenone , prospective blind randomized trial perform two large intensive care unit . Secondary aim monitor electromechanics leave atrium patient SV arrhythmias septic shock .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<mesh_term>Propafenone</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>Septic shock new onset SV arrhythmia LV systolic function normal moderately reduce accord echocardiography . Severe LV systolic dysfunction More 1st degree AV block High dose vasopressor therapy continuous noradrenaline &gt; 1.0 ug/kg.min Known intolerance amiodarone propafenone Absence septic shock Chronic AF Dependence pacemaker Status MAZE procedure</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Supraventricular Arrhythmia</keyword>
	<keyword>Septic shock</keyword>
	<keyword>Propafenone</keyword>
	<keyword>Amiodarone</keyword>
	<keyword>Intensive Care</keyword>
</DOC>